Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia
Frech M, Jehn LB, Stabla K, Mielke S, Steffen B, Einsele H, Metzelder SK, Neubauer A (2017)
Publication Type: Journal article
Publication year: 2017
Journal
Book Volume: 102
Pages Range: e160-e162
Journal Issue: 4
DOI: 10.3324/haematol.2016.160531
Involved external institutions
Philipps-Universität Marburg
Germany (DE)
Universitätsklinikum Würzburg
Germany (DE)
Goethe-Universität Frankfurt am Main
Germany (DE)
Germany (DE)
Universitätsklinikum Würzburg
Germany (DE)
Goethe-Universität Frankfurt am Main
Germany (DE)
How to cite
APA:
Frech, M., Jehn, L.B., Stabla, K., Mielke, S., Steffen, B., Einsele, H.,... Neubauer, A. (2017). Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia. Haematologica, 102(4), e160-e162. https://doi.org/10.3324/haematol.2016.160531
MLA:
Frech, Miriam, et al. "Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with RCSD1-ABL1-positive acute lymphoblastic leukemia." Haematologica 102.4 (2017): e160-e162.
BibTeX: Download